跳至主要内容
临床试验/NL-OMON43095
NL-OMON43095撤回不适用

The effects of protein ingestion to maximize endurance-based training adaptations in untrained healthy young men - Protein supplementation and endurance-based training adaptations

Wageningen Universiteit0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Age between 18 and 30 years of age
  • * BMI between 18.5 * 25 kg/m2
  • * VO2max 50 of lager
  • * Recreationally active, performing sports on a non-competitive basis
  • * Willing to give muscle biopsies
  • * Willing to give blood samples
  • * No use of antibiotics in the past month
  • * No use of illicit drugs
  • * Suitable veins for blood withdrawal
  • * Registered by a general-practitioner
  • * Consumption of alcohol beverages is less than 21 per week
  • * No blood donor during the study
  • * Able to be present and all university visits
  • * Able to perform three exercise sessions weekly for 12 weeks
  • * Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University
  • * Not participating in another scientific study (except EetMeetWeet)
  • * Able to participate during the experimental days en pre tests

排除标准

  • * Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, lactose and gluten intolerance)
  • * Use of medications known to interfere with selected outcome measures (i.e. statins, fenofibrate)
  • * Use of antithrombotic therapy (marcoumar, sintromitis, clopidogrel and NOAC*s).
  • * Diagnosed with liver disease
  • * Diagnosed diabetes mellitus type 1 or 2
  • * (Chronic) injuries of the locomotor system that can interfere with the intervention
  • * Participants with a recent history or current state of COPD
  • * Participants with a recent history or current state of rheumatoid arthritis
  • * Participants with a recent history or current state of musculoskeletal/orthopedic disorders
  • * Participants with a recent history or current state of renal disorder
  • * Participants with a recent history or current state of cognitive impairment
  • * Participants with orthopedic metal implants in the spine and/or upper/lower extremities
  • * Participants with lactose intolerance and/or dairy protein allergy
  • * Participants who are enrolled in an interventional biomedical research project or have received an investigational new drug or product with the last 30 days prior to screening.
  • * Participants on medication, including anticoagulants

研究者

相似试验